Jason G. Matthews

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

Journal: Pharmacological reviews

Published: January 28, 2026

Serglycin modulates inflammation and metabolism in macrophages.

Serglycin modulates inflammation and metabolism in macrophages.

Journal: iScience

Published: September 18, 2025

Baseline AHR expression shapes immune response to pharmacological modulation in PBMCs from pancreatic cancer patients.

Baseline AHR expression shapes immune response to pharmacological modulation in PBMCs from pancreatic cancer patients.

Journal: Frontiers in immunology

Published: June 27, 2025

Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation.

Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation.

Journal: The EMBO journal

Published: June 22, 2025

PARP7 and aryl hydrocarbon receptor differentially regulate mammary cancer cell proliferation and STING-induced type I interferon signalling.

PARP7 and aryl hydrocarbon receptor differentially regulate mammary cancer cell proliferation and STING-induced type I interferon signalling.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 17, 2025

CRISPR screens and quantitative proteomics reveal remodeling of the aryl hydrocarbon receptor-driven proteome through PARP7 activity.

CRISPR screens and quantitative proteomics reveal remodeling of the aryl hydrocarbon receptor-driven proteome through PARP7 activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 10, 2025

Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans.

Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans.

Journal: Cell reports

Published: March 05, 2025

Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltration.

Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltration.

Journal: Biochemical pharmacology

Published: December 04, 2024

Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells.

Small-molecule inhibitor BAY synergizes with gemcitabine through AHR inhibition in pancreatic cancer cells.

Journal: Biochemical pharmacology

Published: November 05, 2024

Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells.

Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells.

Journal: Frontiers in oncology

Published: October 24, 2024

Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration.

Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration.

Journal: Frontiers in immunology

Published: October 18, 2024

Exposure to fine particulate matter in adults is associated with immune cell gene expression related to inflammation, the electron transport chain, and cell cycle regulation.

Exposure to fine particulate matter in adults is associated with immune cell gene expression related to inflammation, the electron transport chain, and cell cycle regulation.

Journal: Environmental epigenetics

Published: October 08, 2024

Showing 1-12 of 80

Last Updated: 09/26/2026